Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Kimball's failed replication of Reinhart-Rogoff finding cited in argument for tempered public response to social science research results

Edin and Shaefer's book on destitute families in America reviewed in NYT

Johnston says rate of daily marijuana use among college students now greater than rate of daily cigarette smoking

Highlights

Deirdre Bloome wins ASA award for work on racial inequality and intergenerational transmission

Bob Willis awarded 2015 Jacob Mincer Award for Lifetime Contributions to the Field of Labor Economics

David Lam is new director of Institute for Social Research

Elizabeth Bruch wins Robert Merton Prize for paper in analytic sociology

Next Brown Bag

Monday, Oct 12
Joe Grengs, Policy & Planning for Social Equity in Transportation

Elisha Renne photo

Postinor use among young women in Southwestern Nigeria: A Research Note

Publication Abstract

Renne, Elisha. 1998. "Postinor use among young women in Southwestern Nigeria: A Research Note." Reproductive Health Matters, 6(11): 107-114.

Postinor is the brand name of a progestogen-only contraceptive tablet, manufactured by a Hungarian firm1 and available in about 25 countries around the world, primarily in parts of Eastern Europe and several developing countries, including Vietnam2 Thailand3 and Nigeria.4 Although Postinor is marketed in Nigeria as a postcoital method for women having infrequent intercourse, it has not been shown to be safe or effective for this indication.5,6 This paper reports on the experience of 26 young women with post-secondary education in south western Nigeria who have used Postinor, how they heard about it, what they know about it and where they buy it. While these young women are primarily using Postinor as a postcoital method, some also are using it to test for pregnancy, to bring on menstruation and in attempts to abort or all of these as needed. It has been proposed that Postinorshould bemarketed asanemergency contraceptive, the only indication for which it has been shown to be effective, but its uses in Nigeria may not change unless the reasons why women use it are addressed.

Browse | Search : All Pubs | Next